Correlation Between UnitedHealth Group and FibroGen

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both UnitedHealth Group and FibroGen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining UnitedHealth Group and FibroGen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between UnitedHealth Group Incorporated and FibroGen, you can compare the effects of market volatilities on UnitedHealth Group and FibroGen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in UnitedHealth Group with a short position of FibroGen. Check out your portfolio center. Please also check ongoing floating volatility patterns of UnitedHealth Group and FibroGen.

Diversification Opportunities for UnitedHealth Group and FibroGen

-0.05
  Correlation Coefficient

Good diversification

The 3 months correlation between UnitedHealth and FibroGen is -0.05. Overlapping area represents the amount of risk that can be diversified away by holding UnitedHealth Group Incorporate and FibroGen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on FibroGen and UnitedHealth Group is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on UnitedHealth Group Incorporated are associated (or correlated) with FibroGen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of FibroGen has no effect on the direction of UnitedHealth Group i.e., UnitedHealth Group and FibroGen go up and down completely randomly.

Pair Corralation between UnitedHealth Group and FibroGen

Assuming the 90 days trading horizon UnitedHealth Group is expected to generate 2.1 times less return on investment than FibroGen. But when comparing it to its historical volatility, UnitedHealth Group Incorporated is 1.78 times less risky than FibroGen. It trades about 0.21 of its potential returns per unit of risk. FibroGen is currently generating about 0.25 of returns per unit of risk over similar time horizon. If you would invest  640.00  in FibroGen on August 30, 2024 and sell it today you would earn a total of  150.00  from holding FibroGen or generate 23.44% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

UnitedHealth Group Incorporate  vs.  FibroGen

 Performance 
       Timeline  
UnitedHealth Group 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in UnitedHealth Group Incorporated are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating technical indicators, UnitedHealth Group may actually be approaching a critical reversion point that can send shares even higher in December 2024.
FibroGen 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in FibroGen are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, FibroGen may actually be approaching a critical reversion point that can send shares even higher in December 2024.

UnitedHealth Group and FibroGen Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with UnitedHealth Group and FibroGen

The main advantage of trading using opposite UnitedHealth Group and FibroGen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if UnitedHealth Group position performs unexpectedly, FibroGen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in FibroGen will offset losses from the drop in FibroGen's long position.
The idea behind UnitedHealth Group Incorporated and FibroGen pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Complementary Tools

Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets